Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area epigenetics parp'

Search results for: 'research area epigenetics parp'

Items 51-60 of 63

Page
per page
  1. 3-Deazaneplanocin A (DZNep) hydrochloride
    A8182 3-Deazaneplanocin A (DZNep) hydrochloride
     1 Citation
    Target: EZH2
    Summary: SAHH and EZH2 inhibitor
      insoluble in EtOH; ≥14.94 mg/mL
  2. PFI-1 (PF-6405761)
    A4184 PFI-1 (PF-6405761)
     1 Citation
    Target: Bromodomains
    Summary: BET inhibitor
      insoluble in H2O; insoluble in EtOH; ≥128.4 mg/mL
  3. BI 2536
    A3965 BI 2536
     1 Citation
    Target: PLK|Bromodomain-containing proteins(BRDs)
    Summary: Plk1 inhibitor,potent and ATP-competitive
      insoluble in H2O; ≥13.04 mg/mL
  4. NU7441 (KU-57788)
    A8315 NU7441 (KU-57788)
     4 Citation
    Target: PI3K|DNA-PK
    Summary: DNA-PK inhibitor
      insoluble in EtOH; insoluble in H2O; ≥4.13 mg/mL
  5. EPZ005687
    A4171 EPZ005687
     2 Citation
    Target: EZH2
    Summary: EZH2 inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥3.86 mg/mL
  6. Barasertib (AZD1152-HQPA)
    A4112 Barasertib (AZD1152-HQPA)
     3 Citation
    Target: Aurora Kinases
    Summary: Aurora Kinase B inhibitor, Potent and selective
      ≥25.4 mg/mL
  7. Hesperadin
    A4118 Hesperadin
     1 Citation
    Target: Aurora Kinases
    Summary: Aurora B kinase inhibitor
      ≥25.85 mg/mL
  8. Aurora A Inhibitor I
    A4126 Aurora A Inhibitor I
    Target: Aurora Kinases
    Summary: Aurora A inhibitor
      ≥29.4 mg/mL
  9. 3-Deazaneplanocin,DZNep
    A1905 3-Deazaneplanocin,DZNep
     6 Citation
    Target: Hydrolase
    Summary: S-adenosylhomocysteine and EZH2 inhibitor
      insoluble in EtOH; ≥17.07 mg/mL
  10. Nicotinamide
    N1651 Nicotinamide
     1 Citation
    Target: PARP
    Summary: PARP-1 inhibitor

Items 51-60 of 63

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 60item
  2. Natural Products 1 item
  3. Peptides 1 item
  4. Peptides & Proteins 1 item
Reversibility
  1. Reversible 2item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 16item
  3. PI3K 1 item
  4. Aurora Kinases 10item
  5. EZH2 2item
  6. Bromodomains 1 item
  7. FLT3 1 item
  8. PLK 1 item
  9. Bromodomain-containing proteins(BRDs) 1 item
  10. Hydrolase 1 item
  11. MEK 1 item
  12. DOT1L 1 item
  13. Nrf2 1 item
  14. Pim 2item
  15. Sir2-like Family Deacetylases (Sirtuins) 3item
  16. PP1 1 item
  17. PP2A 1 item
  18. Src 1 item
  19. Trk Receptors 1 item
  20. JAK 3item
  21. DNA-PK 1 item
  22. Topoisomerases 1 item
  23. DNA Methyltransferases 3item
  24. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  25. CREBBP 2item
  26. EP300 2item
  27. PARP 5item
  28. Fatty-acid-binding proteins (FABPs) 1 item
  29. G9a 1 item
  30. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  31. Cytidine deaminases 1 item
  32. PP4 1 item
  33. c-RET 1 item
  34. Histone Acetyltransferases (HATs) 1 item
  35. Lck 1 item
  36. Sirtuin 1 item
Reported Experiments
  1. Animal Experiments 49item
  2. Cell Experiments 36item
Related Disease
  1. Acute Myeloid Leukemia 7item
  2. Bladder Cancer 2item
  3. Bladder Carcinoma 1 item
  4. Breast Cancer 13item
  5. Cancer 39item
  6. Cervical Cancer 1 item
  7. Chronic Lymphocytic Leukemia 1 item
  8. Colon Cancer 7item
  9. Colorectal Cancer 4item
  10. Diabetes 1 item
  11. Friedreich's Ataxia 1 item
  12. Glioblastoma 1 item
  13. Glioma 2item
  14. Hepatic Cancer 1 item
  15. Hepatocellular Carcinoma 1 item
  16. HIV Infections 1 item
  17. Inflammatory Diseases 1 item
  18. Leukemia 3item
  19. Lung Cancer 4item
  20. Lymphoma 2item
  21. Melanoma 1 item
  22. Mixed Lineage Leukemia 1 item
  23. Multiple Myeloma 3item
  24. Myelofibrosis 1 item
  25. Myeloma 1 item
  26. Neuroblastoma 1 item
  27. Neuronal Protection 1 item
  28. Non-small Cell Lung Cancer 1 item
  29. Ovarian Cancer 5item
  30. Pancreatic Cancer 2item
  31. Prostate Cancer 10item
  32. Psoriasis 1 item
  33. Renal Cancer 1 item
  34. Renal Cell Carcinoma 2item
  35. Rheumatoid Arthritis 2item
  36. Thyroid Cancer 1 item
  37. Type 2 Diabetes 4item